C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris

Citation
H. Koukkunen et al., C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris, ANN MED, 33(1), 2001, pp. 37-47
Citations number
39
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ANNALS OF MEDICINE
ISSN journal
07853890 → ACNP
Volume
33
Issue
1
Year of publication
2001
Pages
37 - 47
Database
ISI
SICI code
0785-3890(200102)33:1<37:CPFIAT>2.0.ZU;2-V
Abstract
BACKGROUND. inflammatory process has been found to play an important role i n the pathogenesis of coronary heart disease (CHD) and in the prognosis of CHD patients, AIM. The aim of this study was to investigate the prognostic Value of C-reactive protein (CRP), fibrinogen, interleukin (IL)-6 and tumou r necrosis factor-alpha (TNF-alpha) in patients with unstable angina pector is (UAP), including factor analysis to assess their joint effects. METHODS. The study comprised 263 consecutive patients (159 men. 104 women; median age 68 years) with UAP. Blood samples for the acute-phase protein an d cytokine determinations were drawn on admission. RESULTS. Coronary mortality during the median follow-up time of 17 months w as 6-fold higher in the highest tertile for CRP and IL-6 and 3.5-fold highe r in the highest tertile for fibrinogen and TNF-alpha than in the respectiv e combined lower tertiles. Factor analysis produced two underlying factors, ie the 'inflammation' factor, including CRP, fibrinogen and IL-6, and the 'injury' factor, including troponin T, creatine kinase MB mass and TNF-alph a. In Cox models, both of these factors were independent predictors of the risk of coronary death and major coronary events (coronary death or nonfata l myocardial infarction). CONCLUSIONS. Elevated levels of acute-phase proteins and cytokines, particu larly CRP and IL-6, are strong predictors of the risk of serious coronary e vents in patients with UAP.